Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 17, 2018
Pharmacy Choice - News - Drug Delivery Systems - July 17, 2018

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 105     Next >>     Go To Page:

7/16/18 - "Hair Removal Compositions and Methods" in Patent Application Approval Process (USPTO 20180177700)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor ROTUNDA, ADAM M., filed on December 28, 2016, was made available online on July 5, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institutio
7/16/18 - Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone?
Aucta Pharmaceuticals, Inc. announced today that it has begun shipping Vigabatrin for Oral Solution, USP, 500 mg, following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application. Aucta's commercial partner Upsher-Smith Laboratories, LLC will launch vigabatrin for oral solution under the brand name Viga
7/16/18 - Clinic introduces customised vitamin infusion therapy [Gulf News (United Arab Emirates)]
Dubai: A Dubai- based cosmetic clinic claims that it has introduced the latest customised vitamin infusion therapy based on the specific needs of a patient. While there are several clinics that offer Intravenous Vitamin Infusion in the UAE, CosmeSurge Dubai said it introduced customised vitamin ingredients based on a client s specific body ne
7/16/18 - CosmeSurge Clinics in UAE to Offer Customised Vitamin Infusion Therapy, an Effective Alternative to Traditional Medicinal Supplements
CosmeSurge Dubai, announced today that it has begun to offer a variety of customised Intravenous Vitamin Infusion therapy options, ranging from vitamins and minerals to a performance enhancement mix, for healthy patients seeking to maximise their health. The clinic is one of several in the UAE region to offer customised therapies based patient?
7/16/18 - Endo Begins Shipment of Authorized Generic Version of Colcrys colchicine, USP in the United States
By a News Reporter-Staff News Editor at Pharma Business Week Endo International plc announced that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping an authorized generic version of Takeda Pharmaceutical's Colcrys 0.6 mg tablets. Endo's subsidiary, Endo Ventures Limited, entered into an exclusive U.S. supply and dist
7/16/18 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 31154) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Antimicrobial Drugs Advisory Committee to discuss new drug application 207356, amikacin liposome inhalation suspension, sponsored by Insmed Inc., for the proposed indication of treatment of nontuberculous mycobacterial lung disease caused by...
7/16/18 - Investigators from Tokyo University of Science Release New Data on Fullerenes (Scanning Techniques for Nanobioconjugates of Carbon Nanotubes)
Our news journalists obtained a quote from the research from the Tokyo University of Science, "Various biological applications using the CNT nanobioconjugates, for example, drug delivery systems and nanobiosensors, have been proposed by many authors. The news correspondents report that additional information may be obtained from K. Umemura, Tokyo..
7/16/18 - Lupin receives FDA approval for generic Nitrofurantoin Capsules USP, 50 mg and 100 mg
Mumbai- Pharma major Lupin announced that it has received final approval for its Nitrofurantoin Capsules USP, 50 mg and 100 mg from the United States Food and Drug Administration to market a generic version of Alvogen Malta Operations Ltd.' s Macrodantin Capsules, 50 mg and 100 mg. Lupin's Nitrofurantoin Capsules USP, 50 mg and 100 mg is the generi
7/16/18 - LYNPARZA olaparib Significantly Delays Disease Progression in Phase 3 First-Line SOLO-1 Trial for Ovarian Cancer
By a News Reporter-Staff News Editor at Pharma Business Week AstraZeneca and Merck, known as MSD outside the United States and Canada, announced positive results from the randomized, double-blinded, placebo-controlled, Phase 3 SOLO-1 trial of LYNPARZA tablets. Sean Bohen, executive vice president, global medicines development and chief medical
7/16/18 - Patent Application Titled "a Piston Washer for a Drug Delivery Device and Drug Delivery Device Incorporating Such Piston Washer" Published Online...
Patent Application Titled "a Piston Washer for a Drug Delivery Device and Drug Delivery Device Incorporating Such Piston Washer" Published Online. By a News Reporter-Staff News Editor at Diabetes Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Bengtsson, Henrik; Carr
7/16/18 - Patent Issued for Auto-Injector (USPTO 10010683)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Henley, Thomas; Cross, David; Jennings, Douglas Ivan; McGinley, Ryan Anthony, filed on April 20, 2016, was published online on July 3, 2018. The assignee for this patent,
7/16/18 - Patent Issued for Combining Electronic Monitoring with Inhaled Pharmacological Therapy to Manage Cardiac Arrhythmias Including Atrial Fibrillation...
Patent Issued for Combining Electronic Monitoring with Inhaled Pharmacological Therapy to Manage Cardiac Arrhythmias Including Atrial Fibrillation. By a News Reporter-Staff News Editor at Pharma Business Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Narasimhan, Rangachari; Belardinelli, Luiz; Schuler, Ca
7/16/18 - Patent Issued for Injector Training Device (USPTO 10013895)
By a News Reporter-Staff News Editor at Pharma Business Week A patent by the inventors Swanson, Kevin David; Sund, Julius, filed on March 12, 2014, was published online on July 3, 2018, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 10013895 is assigned to Antares Pharma Inc.. The follow
7/16/18 - Pulmonary Drug Delivery Devices: Global Market Report 2018-2024 - Lengthy Product Approvals and Issues Pertaining to Drug Stability are Hindering Growth
The "Pulmonary Drug Delivery Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com' s offering. The global pulmonary drug delivery devices market has been dominated by the North America region over the historic period 2016 followed by Europe. Also rising geriatric pop
7/16/18 - Pulmonary Drug Delivery Devices: Global Market Report 2018-2024 - Lengthy Product Approvals and Issues Pertaining to Drug Stability are Hindering Growth - ResearchAndMarkets.com
The "Pulmonary Drug Delivery Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com' s offering. The global pulmonary drug delivery devices market has been dominated by the North America region over the historic period 2016 followed by Europe. Also rising geriatric pop
7/16/18 - Researchers Submit Patent Application, "Hair Removal Methods and Compositions", for Approval (USPTO 20180177701)
By a News Reporter-Staff News Editor at Pharma Business Week From Washington, D.C., NewsRx journalists report that a patent application by the inventor ROTUNDA, ADAM M., filed on September 26, 2017, was made available online on July 5, 2018. No assignee for this patent application has been made. News editors obtained the following quote from the
7/16/18 - Respiratory Devices Market to Grow at 6.5% CAGR Through 2026 to Reach US $31 Bn: Increasing prevalence of respiratory disorders, combined with growing investments in procuring advanced devices are likely to provide an impetus to the growth of the mar
Albany, NY 07/16/2018 A new detailed study titled "Respiratory Devices Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 2026" has recently been submitted to the repository of Market Research Reports Search Engine. According to the research study, the global respiratory devices market is likely to grow at a
7/16/18 - Royal Pharmaceutical Society - Medical device alert All Alaris and Asena GS, GH, CC, TIVA, PK, enteral syringe pumps
The Medicines and Healthcare products Regulatory Agency has issued a medical device alert for all Alaris and Asena GS, GH, CC, TIVA, PK, enteral syringe pumps because of a risk of uncontrolled bolus of medicine.
7/16/18 - Soleo Health Selected by Genentech to Provide Two Limited Distribution Drugs
By a News Reporter-Staff News Editor at Pharma Business Week Soleo Health, an innovative leader in specialty infusion services, announced the company has been selected by Genentech, a world-leading biotechnology company with multiple products on the market and a strong development pipeline, to dispense two limited distribution drugs, Hemlibra
7/16/18 - Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030
The "Subcutaneous Biologics, Technologies and Drug Delivery Systems, 2018-2030" report has been added to ResearchAndMarkets.com' s offering. Biologics constitute a majority of the top selling drugs of today and also represent one of the fastest growing segments of the overall pharmaceutical industry. Having reported over 70% increase in revenues ov
7/16/18 - Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - ResearchAndMarkets.com
The "Subcutaneous Biologics, Technologies and Drug Delivery Systems, 2018-2030" report has been added to ResearchAndMarkets.com' s offering. Having reported over 70% increase in revenues over the past 5-6 years, the market for biologically derived products is currently estimated to be worth more than USD 200 billion. 3 D Medicines AB2 Bio Abbott La
7/16/18 - Vaxart Announces Publication of the Phase 1 Results of its Oral Norovirus Tablet Vaccine in Journal of Clinical Investigation Insight
SOUTH SAN FRANCISCO- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced publication of the comprehensive results of the previously disclosed Phase 1 clinical trial with its norovirus oral tablet vaccine in the Journal of Clinical...
7/15/18 - Delivery: Disposable Medical Equipment For A Period Of 24 Months From The Date Of Signing The Contract. A Detailed Description Of The Order Is Included In Annex 1a, Ie Scopes / S, From Scope No. 1 - 23, [TendersInfo (India)]
Tenders are invited for delivery: disposable medical equipment for a period of 24 months from the date of signing the contract. a detailed description of the order is included in annex 1 a, ie scopes/ s, from scope no. 1- 23,. Range 1 polypropylene syringe range 2 stomach probes range 3 post-operative wound infiltration system range 4 vacuum appara
7/14/18 - CMS Proposes Calendar Year 2019 and 2020 Payment and Policy Changes for Home Health Agencies and Home Infusion Therapy Suppliers
Department of Health and Human Services' Centers for Medicare and Medicaid Services issued the following fact sheet:. On July 2, 2018, the Centers for Medicare& Medicaid Services issued a proposed rule outlining proposed Calendar Year 2019 Medicare payment updates and proposed quality reporting changes for home health agencies, and proposed case-mi
7/14/18 - FDA Announces Voluntary Recall Of Valsartan Following Detection Of Impurity
PETAH TIKVA- The Food and Drug Administration said that Prinston Pharmaceutical Inc. dba Solco Healthcare LLC. is recalling all lots of Valsartan Tablets, 40 mg, 80 mg, 160 mg, and 320 mg; and Valsartan-Hydrochlorothiazide Tablets, 80 mg/12. 5 mg, 160 mg/12. 5 mg, 160 mg/25mg, 320 mg/12. 5 mg, and 320 mg/25mg to the retail level. The US recall incl
Articles(s): 1 - 25 of 105     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415